This retrospective HIPAA-compliant study was approved by the institutional review board and institutional conflict of interest committee.
Obscure gastrointestinal bleeding (OGIB) is defined as gastrointestinal bleeding with no source identified at upper and lower endoscopy (1).
Despite a thorough endoscopic examination, the origin of the blood loss remains unexplained in up to 52% of patients (1), who are usually treated with iron supplementation and observed for further bleeding.
Should further gastrointestinal bleeding occur, as it does in approximately one-half of patients (2), a second upper and lower endoscopy is generally performed in the hope that its results may reveal abnormalities not discovered at the initial examination. If repeat examination findings are negative, further investigation for a smallbowel bleeding source is usually indicated.
Investigation of the small bowel for a bleeding source can be performed by using several modalities. Extended endoscopy may help identify a lesion in about one-third of patients but is often unable to reach the distal small bowel. Barium small-bowel examinations have traditionally been a mainstay in the evaluation of small-bowel disease but lack sensitivity in the evaluation of OGIB (3-5).
Recently, wireless capsule endoscopy has been effectively used in the evaluation of OGIB. The sensitivity of capsule endoscopy for detection of small-bowel lesions that cause gastrointestinal bleeding ranges from 42% to 80% (6-12). While highly effective in the evaluation of smallbowel disease, capsule endoscopy has technical limitations (13, 14) and there is a risk of capsule retention.
Computed tomographic (CT) enterography is a recently developed diagnostic tool for the evaluation of small-bowel disease. This technique uses multidetector CT combined with luminal distention of the small bowel by using neutral enteric oral contrast material. Image acquisition after intravenous contrast material administration is timed to optimize bowel wall enhancement. The ability to exquisitely depict bowel wall abnormalities, as well as extraintestinal disease, has made it an important tool at our institution in the evaluation of small-bowel disease, particularly inflammatory bowel disease (15-18).
Sixty-four-section CT systems permit an increase in both spatial and temporal resolution compared with eight-and 16-section systems. The 32-channel detector and flying focal spot in one system permit a spatial resolution of 0.4 mm in the z-axis-equivalent to the spatial resolution in the transverse plane (19). Additionally, the table speed can be increased, compared with that of most 16-section systems, which permits a volume to be scanned in a more homogeneous vascular phase.
These improvements are theoretically important in detecting small vascular lesions, which often have a vascular blush that is visible for only short periods. The potential advantages of this new technology would seem well suited for the investigation of gastrointestinal bleeding.
Thus, the purpose of our study was to retrospectively evaluate the findings depicted at CT enterography performed with a 64-section CT system and by using neutral enteric contrast material and a three-phase acquisition in patients with OGIB.
MATERIALS AND METHODS
This retrospective Health Insurance Portability and Accountability Actcompliant study was approved by our institutional review board and institutional conflict of interest committee. All patients consented to the use of their medical records for research purposes. The CT system used in this study was provided through a grant from Siemens Medical Solutions (Malvern, Pa). Two investigators (J.G.F., C.H.M.) received salary support from a grant from Siemens Medical Solutions, but they did not participate in the determination of the final diagnosis for each patient.
An additional investigator (J.L.F.) received research support from E-ZEm (Lake Success, NY). The principal investigator and gastroenterologist collaborator (J.E.H. and J.A.A., respectively) maintained exclusive control of all study data.
Patients
Twenty-two consecutive patients with OGIB who were referred by gastroenterologists at our institution for clinically indicated triple-phase CT enterography were included in this study. The study group consisted of 11 men and 11 women (mean age, 55.4 years; age range, 37-83 years) seen during an 8-month period. Nine patients had an overt type of OGIB (defined as the presence of hematochezia and/or melena, negative results at upper and lower endoscopy, and with or without iron deficiency anemia), while 13 patients had an occult type of OGIB (positive fecal occult blood test result and/or iron deficiency anemia, negative result at upper and lower endoscopy, and no melena and hematochezia) (1). All patients were outpatients, and none had clinical signs of active bleeding at CT examination. Comorbid conditions included single cases of colectomy for ulcerative colitis, portal hypertension secondary to portal vein thrombosis, history of resection of periampullary gangliocytic paraganglioma, and von Willebrand disease.
When we first began use of triple-phase CT enterography at our institution, it was performed within an institutional review boardapproved protocol and was approved by our Radiation Safety Committee. each with 1-20 years of endoscopic experience). Fifteen patients underwent at least one additional prior upper and lower endoscopic examination. All endoscopic results were negative for an upper gastrointestinal or colonic source of bleeding. In two patients, fresh blood was seen in the terminal ileum orifice at colonoscopy. Incidental endoscopic findings thought by the endoscopist to be unrelated to recent gastrointestinal bleeding were found in 11 patients and included the following: mild esophagitis, n = 2; hiatal hernia, n = 1; colonic diverticulosis, n = 2; both hiatal hernia and colonic diverticulosis, n = 1; small gastric polyp, n = 1; small colon polyp, n = 3; and postoperative changes in the duodenum secondary to prior periampullary tumor resection, n = 1. In the remaining nine patients, endoscopic findings were negative. 
Triple-Phase CT Enterographic Technique
After a 4-hour fast, patients were given a total of 1800 mL of 0.1% (weight per volume) barium sulfate suspension (Volumen; E-Z-Em) divided into four 450-mL oral doses given every 20 minutes, beginning 60 minutes prior to scanning. The last dose was administered with the patient on the CT table just prior to scanning. All patients successfully ingested the required 1800 mL of enteric contrast material. Glucagon Bolus triggering was performed by the CT technologist by using software (Care Bolus; Siemens Medical Solutions). A region-of-interest cursor was placed over the descending aorta 2 cm above the diaphragm.
The region-of-interest trigger threshold was set at 150 HU, with scanning initiated 6 seconds later. Patients were scanned at 120 kVp and at a quality reference milliampere-seconds of 350 (effective).
Collimation was 32 detector rows and 0.6-mm section thickness, with use of z-flying focal spot, resulting in 64 0.6-mm-wide projections that overlapped by 0.3 mm. Transverse images were reconstructed at a 2-mm section width and a 1-mm interval. Coronal multiplanar images were reconstructed from the retroperitoneal border to the anterior abdominal wall at a 2-mm section width and a 1-mm interval.
Additional images, including three-dimensional, maximum intensity projection, and volume-rendered image reconstructions of data sets, were obtained at each radiologist's discretion but were not routinely used for primary interpretation.
Examination Interpretation and Comparison
Scans were interpreted by one of four gastrointestinal radiologists (J.E.H., 
RESULTS
Twenty-one (95%) of 22 patients underwent technically successful triple-phase enterography. Failure to acquire the delayed phase occurred in one patient (patient 7) for technical reasons (Table 1) . 

Note.-AVM = arteriovenous malformation, FOBT = fecal occult blood test, IDA = iron deficiency anemia.  *The interpreting radiologist ranked focal, increased abnormal enhancement when present as follows: − = no visible enhancement; + = abnormal focal enhancement present; ++ = abnormal focal enhancement present and more conspicuous than in another phase; and +++ = abnormal focal enhancement present and more conspicuous than in other two phases. Two or more phases of enhancement could demonstrate focal abnormal enhancement of equal conspicuity, in which case, both phases were rated as +.
Positive Results at Triple-Phase CT Enterography
Ten of 22 multiphase CT enterographic examinations showed positive findings-demonstrating abnormal bowel wall enhancement (compatible with a bleeding source) or evidence of active bleeding (Table 1) were subsequently confirmed-a jejunal cavernous hemangioma (Fig 1) and active bleeding from jejunal angiodysplasia (Fig 2) . In the third case, both capsule endoscopic and CT enterographic findings were falsely positive, each suggesting active cecal bleeding in a patient with negative colonoscopic results on two subsequent occasions. In the fourth case, with a final diagnosis of portal hypertensive enteropathy, both studies had positive findings in the jejunum. In a final case, CT enterographic and capsule endoscopic results were both positive but were not in agreement on the bleeding source. CT enterography accurately depicted active bleeding from a cecal angiodysplasia, while capsule endoscopic results suggested a small-bowel source (Fig 3) . Subsequent repeat colonoscopic results confirmed a cecal angiodysplasia, which was treated with endoscopically guided laser ablation. Capsule endoscopic results were negative in four of the 10 patients with positive findings at CT examination. In three of these patients, capsule endoscopic results were falsely negative, with CT enterography depicting angiodysplasia of the cecum with an early draining vein (Fig 4) ; a jejunal stromal tumor; and an enhancing jejunal wall mass (Fig 5) , which was confirmed at two subsequent CT enterographic examinations.
In a fourth patient with a negative capsule endoscopic result, CT enterography falsely depicted small-bowel bleeding. At subsequent repeat conventional endoscopy, gastric antral vascular ectasia was found to be the source of gastrointestinal bleeding. One patient with a Meckel diverticulum detected at CT enterography did not undergo capsule endoscopy. CT findings at each of the eight CT enterographic examinations with true-positive findings were visible during at least two of the three phases (Table 1) , with the arterial or delayed phases depicting these lesions or a bleeding source in seven cases each. Progressive increase in attenuation within the lesion during each of the three phases was seen in six patients (patients 1, 3, 5, 7, 9, and 10). Increasing dispersion of contrast material in the dependent portion of the bowel lumen was interpreted as evidence of active bleeding and was seen in three patients.
(One case was false positive.)
Negative Results at Triple-Phase CT Enterography
Twelve of 22 patients had negative findings at CT enterography (Table   2 ). Ten (83%) of 12 patients with negative CT enterographic results had an occult type of OGIB. Only four (33%) of 12 patients underwent capsule endoscopy. Capsule endoscopic results were positive in two cases: a patient with a jejunal lymphangioma (confirmed at surgery) and a patient with bleeding from an ulcer within a hiatal hernia (confirmed at repeat conventional endoscopy). In both cases, capsule endoscopic results revealed the presence of small-bowel blood but did not detect the offending lesion. No corresponding CT abnormalities could be seen in retrospect. Of the remaining 10 patients with negative results at CT enterography, four patients ceased bleeding, four continued to bleed, and two were lost to follow-up. 
DISCUSSION
Reports of the usefulness of CT in evaluating gastrointestinal bleeding are numerous (23-32). In general, only patients with acute, lifethreatening lower gastrointestinal bleeding with no source found at endoscopy (ie, overt OGIB) have been described previously (23) (24) (25) (26) 28, 29, 32) . In contradistinction, all of our patients were outpatients All studies included intravenous contrast material administration except one (33) that included arterial contrast material injection. Either no oral contrast material or neutral enteric contrast material was used in all studies. Section thickness varied from 1.25 to 10 mm. Sensitivity varied from 67% to 79% for detection of active bleeding or specific bowel wall abnormality.
The method of examination used in our study differed from that in previous studies in several ways. All of the patients in our study were examined after ingestion of large volumes of neutral enteric contrast material to distend the bowel lumen and separate the bowel walls, a factor that likely facilitated the detection of extravasated intraluminal contrast material. The use of neutral enteric contrast material not only produces excellent luminal distention but also provides a canvas on which enhancing bowel wall lesions and active bleeding can be detected.
All 22 patients in our study were able to successfully ingest 1800 mL of low-concentration barium solution, which parallels the experience in several other CT enterographic studies employing large volumes of oral contrast material (34-36).
The isotropic spatial resolution provided with our 64-section CT system allows us to visualize small vascular lesions responsible for bleeding in multiple orthogonal planes. The increased temporal resolution permits image acquisition in each of three vascular phases without sacrificing spatial resolution.
Our three-phase acquisition protocol is designed to optimize detection of the most common causes of OGIB (angiodysplasia and small-bowel neoplasms) (37) and to depict active bleeding. Data from angiographic studies suggest that arterial-phase imaging, as well as delayed acquisitions, is necessary to detect small-bowel angiodysplasias-the most common abnormality causing OGIB (37). Boley et al ( 
